Heparin in Congenital Chylothorax and Chylous Ascites
Indian J Pediatr
.
2019 Jul;86(7):660-661.
doi: 10.1007/s12098-019-02956-x.
Epub 2019 Apr 22.
Authors
María Soriano-Ramos
1
,
Elena Orellana-Felis
2
,
María Teresa Moral-Pumarega
3
4
5
6
,
María López-Maestro
3
4
6
,
Concepción de Alba-Romero
3
4
5
6
,
Alberto Galindo-Izquierdo
4
5
6
7
,
Carmen Rosa Pallás-Alonso
3
4
5
6
Affiliations
1
Department of Neonatology, Hospital 12 de Octubre, Avenida de Córdoba s/n, 28041, Madrid, Spain. sorianoramosmaria@gmail.com.
2
Department of Neonatology, Hospital 12 de Octubre, Avenida de Córdoba s/n, 28041, Madrid, Spain.
3
Department of Neonatology, Hospital 12 de Octubre, Biomedical Research Institute i+12, Madrid, Spain.
4
SAMID Network (Spanish Collaborative Maternal and Child Health Research Network), Barcelona, Spain.
5
Complutense University of Madrid, Madrid, Spain.
6
Research Institute i+12 Madrid, Madrid, Spain.
7
Department of Obstetrics and Gynecology, Hospital 12 de Octubre, Madrid, Spain.
PMID:
31012049
DOI:
10.1007/s12098-019-02956-x
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Chylothorax / congenital*
Chylothorax / drug therapy
Chylous Ascites / drug therapy*
Heparin / therapeutic use*
Humans
Infant
Infant, Newborn
Male
Substances
Heparin
Supplementary concepts
Chylothorax, congenital